Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries

László Gulácsi, Fanni Rencz, Márta Péntek, Valentin Brodszky, Ruth Lopert, Noémi Hevér and Petra Baji

The European Journal of Health Economics, 2014, vol. 15, issue 1, 27-34

Abstract: While results must be interpreted with caution, calculating pro rata (cost-effective) prices and per capita GDP/QALY ratios based on CUAs can aid reimbursement decision-making in the absence of analyses using local data. Copyright Springer-Verlag Berlin Heidelberg 2014

Keywords: Cost-utility; Inflammatory conditions; Biologicals; Central and Eastern Europe; HTA; Reimbursement; I 110; I 130 (search for similar items in EconPapers)
Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://hdl.handle.net/10.1007/s10198-014-0591-7 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:15:y:2014:i:1:p:27-34

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-014-0591-7

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().